Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

901
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
901
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

476
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
476
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Legal Liability in Neurology: Navigating Malpractice and Regulatory Compliance.

Seminars in neurology·2025
Same author

Navigating Federal and State Laws Regarding the Prescription of Opioids.

Continuum (Minneapolis, Minn.)·2024
Same author

A Guide for Aspiring Neurology Educators.

Annals of neurology·2024
Same author

Protecting Privacy: Health Insurance Portability and Accountability Act of 1996, Twenty-First Century Cures Act, and Social Media.

Neurologic clinics·2023
Same author

False Claims Act and Anti-Kickback Statute: Avoiding Legal Landmines.

Neurologic clinics·2023
Same author

Medicolegal and Ethical Issues in Neurology.

Neurologic clinics·2023

Related Experiment Video

Updated: Jan 21, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.2K

Liability and Failure to Warn a Patient.

Joseph S Kass, Rachel V Rose

    Continuum (Minneapolis, Minn.)
    |July 30, 2019
    PubMed
    Summary

    Physicians can face liability for prescription medication adverse effects. This article offers strategies to mitigate physician liability and explores pharmaceutical company accountability for side effects like tardive dyskinesia.

    Area of Science:

    • Medicolegal studies
    • Pharmaceutical liability
    • Physician responsibilities

    Background:

    • Physicians must stay informed about prescription medication adverse effects.
    • Understanding liability is crucial for healthcare professionals and pharmaceutical companies.

    Purpose of the Study:

    • To examine physician liability concerning known adverse drug effects.
    • To identify risk mitigation strategies for physicians.
    • To discuss pharmaceutical company liability for drug side effects, including tardive dyskinesia.

    Main Methods:

    • Medicolegal analysis
    • Review of case law and regulatory guidelines
    • Discussion of ethical and legal precedents

    Main Results:

    More Related Videos

    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
    03:47

    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

    Published on: July 12, 2024

    1.1K
    Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
    04:05

    Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

    Published on: June 30, 2023

    2.8K

    Related Experiment Videos

    Last Updated: Jan 21, 2026

    Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
    04:20

    Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

    Published on: October 1, 2019

    6.2K
    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
    03:47

    Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

    Published on: July 12, 2024

    1.1K
    Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
    04:05

    Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

    Published on: June 30, 2023

    2.8K
    • Physician liability is contingent on knowledge of adverse effects and failure to inform or act.
    • Mitigation strategies include thorough patient counseling and documentation.
    • Pharmaceutical companies can be liable for failure to adequately warn about or research side effects.

    Conclusions:

    • Proactive risk management is essential for physicians.
    • Clear communication and adherence to guidelines can reduce medicolegal risks.
    • Accountability for drug-related harm involves both prescribers and manufacturers.